Target | MEDICINES COMPANY (THE) |
---|---|
Bidder | NOVARTIS AG |
Price | £0.00 Full version or £25.00 Light version |
Publication Date | Nov 24, 2019 |
Abstract | On 24 November 2019, it was announced that the quoted Swiss pharmaceuticals group Novartis AG was to make a recommended cash offer to acquire "The Medicines Company", a Nasdaq listed pharmaceuticals business. According to the two companies, the offer of US$85 in cash per share implied a fully diluted equity value for The Medicines Company of US$9.7 billion. The tender offer ... |
Number of pages (Full version) | 0 |
Number of pages (Light version) | 2 |
Format | Adobe Acrobat (Download Acrobat Reader) |
Free Sample | Click Here to Download |
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.